References
- Zicari AM, Capata G, Nebbioso M et al. Vernal Keratoconjunctivitis: an
update focused on clinical grading system. Ital J Pediatr.
2019;45(1):64.
- Nebbioso M, Iannaccone A, Duse M. et al., Vascular Endothelial Growth
Factor (VEGF) Serological and Lacrimal Signaling in Patients Affected
by Vernal Keratoconjunctivitis (VKC). J Ophthalmol. 2018;3850172.
- Nebbioso M, Zicari AM, Celani C et al. Pathogenesis of vernal
keratoconjunctivitis and associated factors. Semin Ophthalmol.
2015;30:340-344.
- Zicari AM, Mora B, Pizzuti A et al. Immunogenetic investigation in
vernal keratoconjunctivitis. Pediatr Allergy Immunol. 2014;25:508-510.
- Zicari AM, Nebbioso M, Lollobrigida V at al. Vernal
keratoconjunctivitis: atopy and autoimmunity. Eur Rev Med Pharmacol
Sci. 2013;17:1419-1423.
- Inada N, Shoji J, Shiraki Y. et al. Histamine H1 and H4 receptor
expression on the ocular surface of patients with chronic allergic
conjunctival diseases. Allergol Int. 2017;66:586-593.
- Zicari AM, Zicari A, Nebbioso M et al. High-mobility group box-1
(HMGB-1) and serum soluble receptor for advanced glycation end
products (sRAGE) in children affected by vernal keratoconjunctivitis,
Pediatr Allergy Immunol. 2014;25:57-63.
- Leonardi A, Di Stefano A, Motterle L, et al. Transforming growth
factor-b/Smad - signalling pathway and conjunctival remodelling in
vernal keratoconjunctivitis. Clin Exp Allergy 2011:41:52–60.
- Leonardi A, Fregona I, Plebani M et al. Th1- and Th2-type cytokines in
chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol
2006;244:1240-1245.
- Leonardi A, Borghesan F, Faggian D, et al. Tear and serum soluble
leukocyte activation markers in conjunctival allergic diseases. Am J
Ophthalmol 2000:129:151–158.
- Pucci N, Caputo R, Mori F, et al. Long-term safety and efficacy of
topical cyclosporine in 156 children with vernal keratoconjunctivitis.
Int J Immunopathol Pharmacol 2010;23:865-871.
- Lambiase A, Leonardi A, Sacchetti M et al., Topical cyclosporine
prevents seasonal recurrences of vernal keratoconjunctivitis in a
randomized, double-masked, controlled 2-year study. J Allergy Clin
Immunol 2011; 128: 896-897.
- Vichyanond P, Pacharn P, Pleyer U, et al. Vernal keratoconjunctivitis:
a severe allergic eye disease with remodeling changes. Pediatr Allergy
Immunol. 2014;25:314-322.
- Dadaci Z, Oncel M, Oncel Acir N. et al. Oxidative stress parameters
and serum magnesium levels in patients with seasonal allergic
conjunctivitis. Cutan Ocul Toxicol. 2016;35:270-274.
- Bacsi A, Dharajiya N, Choudhury BK. et al. Effect of pollen-mediated
oxidative stress on immediate hypersensitivity reactions and
late-phase inflammation in allergic conjunctivitis. J Allergy Clin
Immunol. 2005;116:836-843.
- Smith RE, Ozben T, Saso L. Modulation of Oxidative Stress:
Pharmaceutical and Pharmacological Aspects 2018. Oxid Med Cell Longev.
2019;2019:6380473.
- Spadavecchia L, Fanelli P, Tesse R et al. Efficacy of 1.25% and 1%
topical cyclosporine in the treatment of severe vernal
keratoconjunctivitis in childhood. Pediatr Allergy Immunol.
2006;17:527-532.
- Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin
prick tests in allergy to aeroallergens. Allergy. 2012;67:18‐24.
- Castelli S, Arasi S, Pawankar R, et al. Collection of nasal secretions
and tears and their use in allergology. Curr Opin Allergy Clin
Immunol. 2018;18:1-9.
- Liguori I, Russo G, Curcio F, et al. Oxidative stress, aging, and
diseases. Clin Interv Aging 2018;13:757e72.
- Gritz DC, Montes C, Atalla LR, et al.
Histochemical localization of
superoxide production in experimental autoimmune uveitis. Curr Eye Res
1991;10:927-931.
- Behndig A, Karlsson K, Johansson BO, et al. Superoxide dismutase
isoenzymes in the normal and diseased human cornea. Invest Ophthalmol
Vis Sci 2001;42:2293-2296.
- Ward SK, Wakamatsu TH, Dogru M, et al. The role of oxidative stress
and inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci
2010;51:1994-2002.
- Wakamatsu TH, Dogru M, Ayako I, et al. Evaluation of lipid oxidative
stress status and inflammation in atopic ocular surface disease. Mol
Vis. 2010;16:2465-2475.
- Ma M, Ma X, Cui J et al. Cyclosporin A Protected Cardiomyocytes
Against Oxidative Stress Injury by Inhibition of NF-κB Signaling
Pathway. Cardiovasc Eng Technol. 2019;10:329-343.
- Leonardi A, Doan S, Amrane M et a. A Randomized, Controlled Trial of
Cyclosporine A Cationic Emulsion in Pediatric Vernal
Keratoconjunctivitis: The VEKTIS Study., Ophthalmology.
2019;126:671-681.
- Hingorani M, Calder VL, Buckley RJ, et al. The immunomodulatory effect
of topical cyclosporin A in atopic keratoconjunctivitis. Invest
Ophthalmol Vis Sci 1999:40:392–399.